Psychosomatic Research in Hypertension: The Lack of Impact of Decades of Research and New Directions to Consider

Journal of Clinical Hypertension

Volumn 14, Issue 10, 2012, Pages 657-664

  Mann, Samuel J ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ALPRAZOLAM; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LABETALOL; RENIN INHIBITOR;

ANGER; ANTIHYPERTENSIVE THERAPY; ANXIETY; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; COMORBIDITY; COPING BEHAVIOR; DISEASE SEVERITY; DRUG EFFICACY; EMOTIONAL STRESS; FATIGUE; FEEDBACK SYSTEM; HUMAN; HYPERTENSION; JOB STRESS; LABILE HYPERTENSION; LEISURE; MEDICAL RESEARCH; PAROXYSMAL HYPERTENSION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOSOMATICS; PSYCHOTHERAPY; PSYCHOTRAUMA; SEXUAL DYSFUNCTION; TREATMENT INDICATION; TREATMENT RESPONSE; XEROSTOMIA;

ADAPTATION, PSYCHOLOGICAL; ANTIHYPERTENSIVE AGENTS; BIOMEDICAL RESEARCH; BLOOD PRESSURE; HUMANS; HYPERTENSION; PSYCHOPHYSIOLOGIC DISORDERS; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 84867099493     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2012.00686.x     Document Type: Article

References (77)

1. Hunyor SN, Henderson RJ. The role of stress management in blood pressure control: why the promissory note has failed to deliver. J Hypertens. 1996;14:413-418.
2. Pickering TG, Gerin W. Cardiovascular reactivity in the laboratory and the role of behavioral factors in hypertension: a critical review. Ann Behav Med. 1990;12:3-16.
3. Krantz DS, Manuck SB. Acute psychophysiologic reactivity and risk of cardiovascular disease: a review and methodologic critique. Psychol Bull. 1984;96:435-464.
4. Light KC. Cardiovascular responses to effortful active coping: implications for the role of stress in hypertension development. Psychophysiology. 1981;18:216-225.
5. Fauvel JP, M'Pio I, Quelin P, et al. Neither perceived job stress nor individual cardiovascular reactivity predict high blood pressure. Hypertension. 2003;42:1112-1116.
6. Parati G, Pomidossi G, Casadei R, et al. Comparison of the cardiovascular effects of different laboratory stressors and their relationship with blood pressure variability. J Hypertens. 1988;6:481-488.
7. Floras JS, Hassan MO, Jones JV, Sleight P. Pressor responses to laboratory stresses and daytime blood pressure variability. J Hypertens. 1987;5:715-719.
8. Julius S, Jones K, Schork N, et al. Independence of pressure reactivity from pressure levels in Tecumseh, Michigan. Hypertension. 1991;17:III12-III21.
9. Jorgensen RS, Johnson BT, Kolodziej ME, Schreer GE. Elevated blood pressure and personality: a meta-analytic review. Psychol Bull. 1996;120:293-320.
10. Suls J, Wan CK, Costa PT Jr. Relationship of trait anger to resting blood pressure: a meta-analysis. Health Psychol. 1995;14:444-456.
11. Cottier C. Personality traits and hypertension: an overview. In: Julius S, Birkenhäger WH, Reid JL, eds. Handbook of Hypertension Behavioral Factors in Hypertension. Amsterdam: Elsevier; 1987:123-140.
12. Kahn HA, Medalie JH, Neufeld HN, et al. The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J. 1972;84:171-182.
13. Sparrow D, Garvey AJ, Rosner B, Thomas HE Jr. Factors in predicting blood pressure change. Circulation. 1982;65:789-794.
14. Goldberg EL, Comstock GW, Graves CG. Psychosocial factors and blood pressure. Psychol Med. 1980;10:243-255.
15. Markovitz JH, Matthews KA, Kannel WB, et al. Psychological predictors of hypertension in the Framingham study: is there tension in hypertension? JAMA. 1993;270:2439-2443.
16. Monk M. Psychologic status and hypertension. Am J Epidemiol. 1980;112:200-208.
17. Cottington EM, Brock BM, House JS, Hawthorne VM. Psychosocial factors and blood pressure in the Michigan statewide blood pressure survey. Am J Epidemiol. 1985;121:515-529.
18. Mann SJ, James GD. Defensiveness and essential hypertension. J Psychosom Res. 1998;45:139-148.
19. Jula A, Salminen JK, Saarijarvi S. Alexithymia: a facet of essential hypertension. Hypertension. 1999;33:1057-1061.
20. Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension? JAMA. 1988;259:225-228.
21. Rostrup M, Kjeldsen SE, Eide IK. Awareness of hypertension increases blood pressure and sympathetic responses to cold pressor test. Am J Hypertens. 1990;3:912-917.
22. Pieper C, LaCroix AZ, Karasek RA. The relation of psychosocial dimensions of work with coronary heart disease risk factors: a meta-analysis of five United States data bases. Am J Epidemiol. 1989;129:483-494.
23. Light KC, Turner JR, Hinderliter AL. Job strain and ambulatory work blood pressure in healthy young men and women. Hypertension. 1992;20:214-218.
24. Frommer MS, Edye BV, Mandryk JA, et al. Systolic blood pressure in relation to occupation and perceived work stress. Scand J Work Environ Health. 1986;12:476-485.
25. Mann SJ. Job stress and blood pressure: a critical appraisal of reported studies. Curr Hypertens Rev. 2006;2:127-138.
26. Eisenberg DM, Delbanco TL, Berkey CS, et al. Cognitive behavioral techniques for hypertension: are they effective? Ann Intern Med. 1993;118:964-972.
27. Linden W, Chambers L. Clinical effectiveness of non-drug treatment for hypertension: a meta- analysis. Ann Behav Med. 1994;16:35-45.
28. van Montfrans GA, Karemaker JM, Wieling W, Dunning AJ. Relaxation therapy and continuous ambulatory blood pressure in mild hypertension: a controlled study. BMJ. 1990;300:1368-1372.
29. Johnston DW, Gold A, Kentish J, et al. Effect of stress management on blood pressure in mild primary hypertension. BMJ. 1993;306:963-966.
30. Alexander CN, Schneider RH, Staggers F, et al. Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis. Hypertension. 1996;28:228-237.
31. Peled-Ney R, Silverberg DS, Rosenfeld JB. A controlled study of group therapy in essential hypertension. Isr J Med Sci. 1984;20:12-15.
32. Graham TW, Kaplan BH, Cornoni-Huntley JC, et al. Frequency of church attendance and blood pressure elevation. J Behav Med. 1978;1:37-43.
33. Hamer M, Batty GD, Stamatakis E, Kivimaki M. Hypertension awareness and psychological distress. Hypertension. 2010;56:547-550.
34. Weinberger DA, Schwartz GE, Davidson RJ. Low-anxious, high-anxious, and repressive coping styles: psychometric patterns and behavioral and physiological responses to stress. J Abnorm Psychol. 1979;88:369-380.
35. Sommers-Flanagan J, Greenberg RP. Psychosocial variables and hypertension: a new look at an old controversy. J Nerv Ment Dis. 1989;177:15-24.
36. Linden W, Feuerstein M. Essential hypertension and social coping behavior: experimental findings. J Human Stress. 1983;9:22-31.
37. Wennerholm MA, Zarle TH. Internal-external control, defensiveness, and anxiety in hypertensive patients. J Clin Psychol. 1976;32:644-648.
38. Crowne DP, Marlowe D. A new scale of social desirability independent of psychopathology. J Consult Psychol. 1960;24:349-354.
39. King AC, Taylor CB, Albright CA, Haskell WL. The relationship between repressive and defensive coping styles and blood pressure responses in healthy, middle-aged men and women. J Psychosom Res. 1990;34:461-471.
40. Shapiro D, Jamner LD, Goldstein IB. Ambulatory stress psychophysiology: the study of "compensatory and defensive counterforces" and conflict in a natural setting. Psychosom Med. 1993;55:309-323.
41. Warrenburg S, Levine J, Schwartz GE, et al. Defensive coping and blood pressure reactivity in medical patients. J Behav Med. 1989;12:407-424.
42. Todarello O, Taylor GJ, Parker JD, Fanelli M. Alexithymia in essential hypertensive and psychiatric outpatients: a comparative study. J Psychosom Res. 1995;39:987-994.
43. Lesser IM. Current concepts in psychiatry. Alexithymia. N Engl J Med. 1985;312:690-692.
44. Winkleby MA, Ragland DR, Syme SL. Self-reported stressors and hypertension: evidence of an inverse association. Am J Epidemiol. 1988;127:124-134.
45. Meyer E, Derogatis LR, Miller M, Reading A. Hypertension and psychological distress. Psychosomatics. 1978;19:160-163, 7-8.
46. Borhani NO, Borkman TS. The Alameda County Blood Pressure Study. Berkley, CA: State of California Department of Public Health; 1968.
47. MacMillan HL, Fleming JE, Trocme N, et al. Prevalence of child physical and sexual abuse in the community. Results from the Ontario Health Supplement. JAMA. 1997;278:131-135.
48. McCauley J, Kern DE, Kolodner K, et al. Clinical characteristics of women with a history of childhood abuse: unhealed wounds. JAMA. 1997;277:1362-1368.
49. Lazerus RS. The costs and benefits of denial. In: Bresnitz S, ed. The Denial of Stress. New York, NY: International Universities Press; 1983:1-33.
50. Mann SJ. Drug therapy for resistant hypertension: simplifying the approach. J Clin Hypertens (Greenwich). 2011;13:120-130.
51. Raskin P, Guthrie R, Flack J, et al. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide. J Hum Hypertens. 1999;13:683-687.
52. Grassi G, Cattaneo BM, Seravalle G, et al. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension. 1998;31:68-72.
53. Mann SJ. Neurogenic essential hypertension revisited: the case for increased clinical and research attention. Am J Hypertens. 2003;16:881-888.
54. Narkiewicz K, Somers VK. The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J Hypertens. 1997;15:1613-1619.
55. Mathias CJ. Management of hypertension by reduction in sympathetic activity. Hypertension. 1991;17:III69-III74.
56. Wallace JD, Levy LL. Blood pressure after stroke. JAMA. 1981;246:2177-2180.
57. Mills PJ, Dimsdale JE. Cardiovascular reactivity to psychosocial stressors. A review of the effects of beta-blockade. Psychosomatics. 1991;32:209-220.
58. Pandhi P, Sharma PL, Sharma BK, Wahi PL. Comparative effect of propranolol and labetalol on isometric exercise and cold stress induced increase in arterial blood pressure. Int J Clin Pharmacol Ther Toxicol. 1986;24:249-253.
59. Julius S. The blood pressure seeking properties of the central nervous system. J Hypertens. 1988;6:177-185.
60. Dimsdale JE, Mills P, Ziegler M, et al. Converting enzyme inhibition and blood pressure reactivity to psychological stressors. Hypertension. 1992;20:210-213.
61. Shapiro AP. Pressor responses to noxious stimuli in hypertensive patients. Effects of reserpine and chlorothiazide. Circulation. 1962;26:242-250.
62. Mann SJ, Gerber LM. Low-dose alpha/beta blockade in the treatment of essential hypertension. 2001.
63. Searle M, Dathan R, Dean S, et al. Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial. Eur J Clin Pharmacol. 1990;39:299-300.
64. Holtzman JL, Kaihlanen PM, Rider JA, et al. Concomitant administration of terazosin and atenolol for the treatment of essential hypertension. Arch Intern Med. 1988;148:539-543.
65. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA. 2000;283:1967-1975.
66. Pasic J, Shapiro D, Jamner LD, Hui KK. Hostility and the response to diuretic in mild-to-moderate hypertension. Am J Hypertens. 1994;7:503-508.
67. Mann SJ, Gerber LM. Psychological characteristics and responses to antihypertensive drug therapy. J Clin Hypertens (Greenwich). 2002;4:25-34.
68. Anderson GH Jr, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens. 1994;12:609-615.
69. Mann SJ, Parikh NS. A simplified mechanistic algorithm for treating resistant hypertension: efficacy in a retrospective study. J Clin Hypertens (Greenwich). 2012;14:191-197.
70. Mann SJ. The clinical spectrum of labile hypertension: a management dilemma. J Clin Hypertens (Greenwich). 2009;11:491-497.
71. Mann SJ. Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment. Arch Intern Med. 1999;159:670-674.
72. Mann SJ. Severe paroxysmal hypertension (pseudopheochromocytoma). Curr Hypertens Rep. 2008;10:12-18.
73. Pacak K, Linehan WM, Eisenhofer G, et al. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med. 2001;134:315-329.
74. Mann SJ. Severe paroxysmal hypertension: an automatic syndrome and its relationship to repressed emotions. Psychosomatics. 1996;37:444-450.
75. Sharabi Y, Goldstein DS, Bentho O, et al. Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma. J Hypertens. 2007;25:2286-2295.
76. Grossman E, Oren S, Garavaglia GE, et al. Disparate hemodynamic and sympathoadrenergic responses to isometric and mental stress in essential hypertension. Am J Cardiol. 1989;64:42-44.
77. Narkiewicz K, Winnicki M, Schroeder K, et al. Relationship between muscle sympathetic nerve activity and diurnal blood pressure profile. Hypertension. 2002;39:168-172.